Finance

Beta
Lists
NUZ:ASX
Neurizon Therapeutics Ltd
A$0.060
0.00%
(0.00) 1D
Jun 25, 1:58:43 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NUZ...
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
45.82M
Avg. vol.
906.13K
Volume
2.31M
52-wk high
A$0.18
52-wk low
A$0.06
EPS
-A$0.03
Shares outstanding
763.64M
No. of employees
52
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
45.82M
Avg. vol.
906.13K
Volume
2.31M
52-wk high
A$0.18
52-wk low
A$0.06
EPS
-A$0.03
Shares outstanding
763.64M
No. of employees
52
News stories
From sources across the web
About Neurizon Therapeutics Ltd
CEO-
Employees52
Founded2000
Headquarters-
SectorPharmaceutical industry
Websiteneurizon.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.20K
3.20K
2.99M
2.99M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.02M
3.02M
4.12M
4.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.54M
1.54M
1.40M
1.40M
Operating expense
4.72M
4.72M
5.70M
5.70M
Total operating expenses
4.72M
4.72M
5.70M
5.70M
Operating income
-4.72M
-4.72M
-2.72M
-2.72M
Other non operating income
-
-
-
-
EBT including unusual items
-4.66M
-4.66M
-2.77M
-2.77M
EBT excluding unusual items
-4.66M
-4.66M
-2.77M
-2.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.66M
-4.66M
-2.77M
-2.77M
Net profit margin
-145,620.04%
-145,620.04%
-92.70%
-92.70%
Earnings per share
-
-
-
-
Interest and investment income
59.80K
59.80K
11.89K
11.89K
Interest expense
-
-
-63.39K
-63.39K
Net interest expenses
59.80K
59.80K
-51.50K
-51.50K
Depreciation and amortization charges
22.00
22.00
359.00
359.00
EBITDA
-4.72M
-4.72M
-2.72M
-2.72M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer